Clinical Trials Logo

Clinical Trial Summary

For hemodialysis subjects not receiving ESAs with anemia associated with chronic kidney disease, evaluate Hb correction and maintenance effect and safety of MT-6548.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03461146
Study type Interventional
Source Mitsubishi Tanabe Pharma Corporation
Contact
Status Completed
Phase Phase 3
Start date March 5, 2018
Completion date December 17, 2018

See also
  Status Clinical Trial Phase
Completed NCT03439137 - Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan Phase 3